US Stock MarketDetailed Quotes

MRSN Mersana Therapeutics

Watchlist
  • 1.310
  • -0.180-12.08%
Close Aug 16 16:00 ET
  • 1.291
  • -0.019-1.45%
Post 17:29 ET
160.70MMarket Cap-1541P/E (TTM)

Mersana Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Mersana Therapeutics Q2 2024 Earnings Date

Currency：USDAug 13, 2024

Estimate
(YoY)		 Actual
(YoY)		 Vs Estimate
(% Chg)
Revenue
8.72M
2.29M
-6.43M
Miss Est.
-18.15%
-78.48%
-73.71%
EPS
-0.17
-0.20
-0.03
Miss Est.
+63.84%
+57.45%
-17.72%
Analyst Rating
Strong Buy

Aug 16, 2024

Mersana Therapeutics Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 9 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2024/Q4-- / 6.602M--
--2024/Q3-- / 7.392M--
Aug 13, 20242024/Q22.293M / 8.721M--
May 9, 20242024/Q19.245M / 8.289M--
Feb 28, 20242023/Q410.701M / 14.772M--
DatePeriodRevenue/EstimateEarnings Call
--2024/Q4-- / 6.602M--
--2024/Q3-- / 7.392M--
Aug 13, 20242024/Q22.293M / 8.721M--
May 9, 20242024/Q19.245M / 8.289M--
Feb 28, 20242023/Q410.701M / 14.772M--

Unlock Free Earnings Estimates

Mersana Therapeutics Earnings Reports

  • Mersana Therapeutics | 10-Q: Q2 2024 Earnings Report

    Aug 13 09:02 ET

  • Mersana Therapeutics | 10-Q: Q1 2024 Earnings Report

    May 9 09:02 ET

  • Mersana Therapeutics | 10-K: FY2023 Annual Report

    Feb 28 08:52 ET

  • Mersana Therapeutics | 10-Q: Q3 2023 Earnings Report

    Nov 7, 2023 08:42 ET

    • Read more

    Analysis

    Analyst Rating

    Updated: Aug 16, 2024

    Strong Buy

    • Buy

      75.00%

    • Hold

      25.00%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    US
    Overall
    Symbol
    Latest Price
    % Chg